STrategically Acquired Gradient Echo (STAGE) imaging, part II: Correcting for RF inhomogeneities in estimating T1 and proton density

Category: Papers, Resources



To develop a method for mapping the B1 transmit (B1t) and B1 receive (B1r) fields from two gradient echo datasets each with a different flip angle and from these two images obtain accurate T1 and proton density (PD) maps of the brain.


A strategically acquired gradient echo (STAGE) data set is collected using two flip angles each with multiple echoes. The B1t field extraction was based on forcing cortical gray matter and white matter to have specific T1 values and fitting the resulting B1t field to a quadratic function. The B1r field extraction was based on synthesizing isointense images despite there being two or three tissue types present in the brain. This method was tested on 10 healthy volunteers and 20 stroke patients from data acquired at 3.0 Tesla.


With the knowledge of the B1t and B1r fields, the uniformity of tissue T1 and PD maps was considerably improved. T1 values were measured for both the midbrain and basal ganglia and found to be in good agreement with the literature.

Discussion and Conclusions:

STAGE provides a practical way to assess the B1t and the B1r fields which can then be used to correct for spatial variations in the images.

New & Related

All Resources

Do you really have to sacrifice MRI image quality for speed?

Do you really have to sacrifice MRI image quality for speed?

To understand the significance of the SpinTech MRI STAGE software platform, it helps to begin by asking a question: Given that MRI is an incredibly powerful diagnostic tool for neurological diseases like Alzheimer’s, dementia, Parkinson’s and multiple sclerosis (MS),...

read more
Editorial: Quantitative Susceptibility Mapping in Neurodegeneration

Editorial: Quantitative Susceptibility Mapping in Neurodegeneration

The purpose of this study was to evaluate the effect of resolution on iron content using quantitative susceptibility mapping (QSM); to verify the consistency of QSM across field strengths and manufacturers in evaluating the iron content of deep gray matter (DGM) of the human brain using subjects from multiple sites; and to establish a susceptibility baseline as a function of age for each DGM structure using both a global and regional iron analysis.

read more